MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions
View by Date

Monday, September 23, 2019

1:45pm-3:15pm
Steroid responsive chorea in Moyamoya disease: illustrative cases

S. Medarametla, N. Boraiah, S. Swamy, S. Raju (Bangalore, India)

Choreas (Non-Huntington’s Disease)  ·  Les Muses, Level 3
1:45pm-3:15pm
Stiff Limb Syndrome Progressing to Stiff Man Syndrome in a non-diabetic man

T. Ali, D. Ginjupally, Z. Guduru (Lexington, KY, USA)

Other  ·  Agora 2 West, Level 2
1:45pm-3:15pm
Stigma and Quality of life in Parkinson’s disease patients on different treatment regimens

O. Vanta, L. Perju-Dumbrava, L. Perju-Dumbrava (Cluj-Napoca, Romania)

Quality of Life  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Stigma in Egyptian patients with Parkinson’s disease

M. Salim, A. Helmy, A. Shalash, E. Abdel Dayem (Cairo, Egypt)

Quality of Life  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Stimulation challenge test after STN DBS improves postoperative satisfaction in patients with Parkinson’s Disease

V. Geraedts, J. van Hilten, J. Marinus, A. Mosch, K. Naarding, C. Hoffmann, N. Vd Gaag, MF. Contarino (Leiden, Netherlands)

Quality of Life  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Study of eye movements as a tool in the diagnosis hereditary ataxias

D. Gasca Saldaña, Y. Sánchez Jimenez, MC. Boll (Mexico City, Mexico)

Ataxia  ·  Les Muses, Level 3
1:45pm-3:15pm
Study of prevalence of Axis-1 DSM-4 psychiatric disorders in patients with parkinsonism in a rural movement disorder clinic in Western India

D. Desai, S. Singh, S. Desai (Anand, India)

Psychiatric Manifestations  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Study on the effect of levodopa administration on serum zinc levels in Parkinson’s disease patients

H. Matsuyama, K. Matsuura, H. Ishikawa, Y. Hirata, N. Kato, A. Niwa, Y. Narita, H. Tomimoto (Tsu, Japan)

Other  ·  Agora 2 West, Level 2
1:45pm-3:15pm
Subcortical atrophy is an early event in Huntington’s disease

N. Rocha, L. Latham, O. Charron, G. Papadimitropoulos, G. Colpo, L. Freeman, E. Furr Stimming, A. Teixeira (Houston, TX, USA)

Huntington’s Disease  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Successful altruistic living kidney donation in a patient with Huntington’s disease

C. Cooper, S. Chen, B. Bernard, J. Goldman (Chicago, IL, USA)

Huntington’s Disease  ·  Agora 3 West, Level 3
  • «Previous Page
  • 1
  • …
  • 61
  • 62
  • 63
  • 64
  • 65
  • …
  • 75
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley